Skip to Content

Ensituximab

https://www.roxropharma.com/web/image/product.template/261097/image_1920?unique=778ea14
Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer[1][2].

1,521.20 € 1521.2 EUR 1,521.20 €

1,521.20 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days